// App-Quantinova.ai

PB2211 : PLASMA REG3Α MAY PREDICT PROGNOSIS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CAR-T BRIDGING TRANSPLANTATION

Researchers

Presenter

  • man chen

Principal Investigators

  • wei zhao

  • Hui Wang

Medical Centers

  • beijing Lu daopei hospital,beijing,Chine

  • clinical lab,Hebei Yanda Lu Daopei Hospital,Langfang, sanhe,Cina

  • beijing Lu daopei hospital,beijing,Chine

  • clinical lab,Hebei Yanda Lu Daopei Hospital,Langfang, sanhe,Cina

  • beijing Lu daopei hospital,beijing,Chine

  • clinical lab,Hebei Yanda Lu Daopei Hospital,Langfang, sanhe,China

  • clinical lab,Hebei Yanda Lu Daopei Hospital,Langfang, sanhe,Cina

  • beijing Lu daopei hospital,beijing,Chine

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Cluster of Differentiation 19

  • Cluster of differentiation 7

Drug/Treatment

  • Allopurinol

  • REG3

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved